About Us

Genomenon is a genomics intelligence company in the lead position to be the first to curate the entire human genome. Our team is dedicated to improving the quality of patients’ lives by characterizing the genomic drivers of genetic disease and cancer. Genomenon's curation process emphasizes the clinical relevance of genetic findings, ensuring that curated data directly supports accurate diagnosis and effective treatment decisions.

Blending the power of AI with the precision of genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development.

An image of our team of genomic experts that aid your genomic research needs.
An image of our team of variant curators that aid your genomic research needs.

Genomenon, a name signifying “born out of need” in ancient Greek, perfectly encapsulates the genesis of our journey.

In his clinical practice and genomic research, co-founder Dr. Mark Kiel was frustrated with the painfully slow and time-consuming process of manual curation. He was also well aware of the diagnostic odyssey that thousands of rare disease patients and families face as he and his twin brother had hypodontia, or missing adult teeth, in their youth. Living with a rare condition as a child focused Mark’s attention on genetics and his desire to make an impact on rare diseases.

Genomenon was founded in 2014 to address this pressing need for faster, more comprehensive variant interpretation by combining expert curation with unique machine-learning methods designed to keep up with the pace of new publications and present the most relevant information to researchers.

Today, Genomenon empowers scientists, researchers and clinicians at pharmaceutical companies, clinical labs, and universities to more thoroughly understand diseases at a molecular level.

Genomenon is headquartered in Ann Arbor, Michigan.

Expertise in Genomics

Our team of genetic scientists and expert curators review scientific publications and leverage our genomics focused artificial intelligence to analyze and interpret vast amounts of genomic data. This expertise enables us to provide unparalleled genomic insights that support patient diagnosis and precision medicine development.

With Genomenon's software, data, and services, users can simplify complex genetic data into actionable insights, driving advancements in clinical research and precision medicine.

Our Offerings Include

Software

Genomenon's Mastermind Genomic Intelligence Platform is the world's most comprehensive genomic database. It supports research & helps diagnostic companies accelerate their workflow. Mastermind provides access to information on 27 million+ variants, 10M+ full text articles as well as curated germline variant content. Clinicians and researchers can accelerate throughput, increase diagnostic yield, and be confident they have the information and insights needed to make an accurate diagnosis.

Genomenon's Cancer Knowledgebase is a powerful diagnostic & research tool designed to interpret the most complex cancer genomic profiles and helps advance clinical decision support and precision medicine efforts in Oncology. CKB is used to interpret cancer variants, connecting them to therapies and clinical trials. With information on 2,100+ genes, 15,000+ trials, and 48,000+ cancer variants, it streamlines the process of identifying critical information - improving patient diagnostics and treatment outcomes.

Data

Gain access to Genomenon’s expansive, constantly updated database of curated genomic data without leaving your existing workflow. Our Data solutions are trusted by clinical diagnostic labs, providing seamless integration of our expertly curated and indexed files. Unlock the  deep insights and comprehensive data from our software, all integrated into your pipeline for efficient, accurate analyses.

Services

Our expert team provides tailored consulting services to support your genomic projects. From custom variant analysis to regulatory guidance, we ensure you have the expert insights needed for your specific genomic needs.

Every accolade is a testament to our team and our mission to make genomic information actionable

Our Leadership Team

Working together to make genomic information actionable.

Mike Klein
Chief Executive Officer

With over 25 years of developing, building and growing 4 different high-tech companies, Mike raised over $50M in capital and had several successful investor exits.

Mark J. Kiel, MD, PhD
Chief Scientific Officer & Co-Founder

Dr. Mark Kiel is the co-founder and chief scientific officer at Genomenon, where he oversees the company's scientific direction and product development. Mark received his MD/PhD in Clinical Pathology at the University of Michigan. He founded Genomenon to address the challenge of connecting researchers with evidence in the literature to help diagnose and treat patients with rare genetic diseases and cancer.

Sam Globus, PhD
Chief Operating Officer

Sam brings a wealth of experience in genomic product development and operations to the team, and manages the rapid growth of our data science and variant curation work.

Brian Groark
Chief Financial Officer

Brian is an actively licensed CPA and MBA with experience leading finance teams at PE backed technology companies. He has a proven track record of success in financial reporting, fundraising, digital transformations and M&A.

Brittnee Jones, PhD
Principal Technical Product Manager, AI & Data Engineering

Data-driven product manager with expertise in clinical genomics, global team building, and driving customer-focused products forward through market analysis and cross-functional collaboration.

Jon Murray
Vice President of Sales

Jon has been in the informatics market for over 25 years. He brings a track record of successful sales management and team building.

Colleen McMillen
Vice President of Marketing

Colleen is an accomplished communications and marketing executive in the health space with more than two decades of experience delivering high-impact positioning for products, organizations and executive teams.

Dave Anstey
Vice President of Pharma Business Development

Dave has almost 30 years of experience selling scientific software with a track record of building successful sales teams and meaningful customer relationships.

Jonathan Eads
Vice President of Engineering

As VP of Technology Jonathan Eads spearheads Genomenon's software development team leading the technical vision and implementation for the company technologies, including its AI strategy. He brings 25 years of experience in genomics, drug discovery, bioinformatics, and AI/ML software application development, with extensive experience building and leading engineering teams to deliver operational excellence.

Erin McCann
Head of People

Erin McCann is an HR and People leader with 20+ years of diverse experience. She supports startup teams through rapid growth, cultivating inclusive organizational cultures.

Jeffrey Bissonnette
Senior Director of Genomic Curation

With a background in genetic counseling, Jeffrey brings over a decade of experience in clinical genetics, variant interpretation, and software tools for variant analysis.

Kojo Elenitoba-Johnson, MD
Co-Founder & Advisor

Kojo is the James Ewing Alumni Chair of Pathology for the Department of Pathology and Laboratory Medicine at Memorial Sloan Kettering Cancer Center.

Megan Lim, MD, PhD
Co-Founder & Advisor

Megan is the Director of the Lymphoma Translational Research Program at Memorial Sloan Kettering Cancer Center.

Our Core Values

Customer &
Patient Centric

We put customers and patients first in everything that we do.

Always Learning

We approach challenges with curiosity & a growth mindset to imagine what can be, not what is.

Data Driven

We ask questions and look to the evidence for answers.

Humbly
Confident

We have confidence in who we are, where we're going, and how we're getting there.

True
Grit

We embody passion, persistence, and aren't afraid of hard work.